Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Burns D002056 34 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Infertility, Male D007248 11 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Kawasaki T and Snyder F Synthesis of a novel acetylated neutral lipid related to platelet-activating factor by acyl-CoA:1-O-alkyl-2-acetyl-sn-glycerol acyltransferase in HL-60 cells. 1988 J. Biol. Chem. pmid:3422635
Smith SK and Kelly RW Effect of platelet-activating factor on the release of PGF-2 alpha and PGE-2 by separated cells of human endometrium. 1988 J. Reprod. Fertil. pmid:3422322
Criscuoli M and Subissi A Catecholamines released from the adrenal medulla exert a compensatory, protective effect at beta 2-adrenoceptors against Paf-induced death in mice. 1988 Br. J. Pharmacol. pmid:2894872
Vivier E et al. Immunoregulatory functions of paf-acether. II. Decrease of CD2 and CD3 antigen expression. 1988 Eur. J. Immunol. pmid:2895712
Michel L et al. Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin. 1988 J. Allergy Clin. Immunol. pmid:2899102
Michel L et al. Release of PAF-acether and precursors during allergic cutaneous reactions. 1988 Lancet pmid:2899817
Bourdillat B et al. Hispidulin, a natural flavone, inhibits human platelet aggregation by increasing cAMP levels. 1988 Eur. J. Pharmacol. pmid:2836213
Toyofuku T et al. Pulmonary vascular response to platelet-activating factor in conscious sheep. 1988 Am. J. Physiol. pmid:3414811
Nasmith PE and Grinstein S Cytosolic calcium, oxygen consumption and the intracellular pH of stimulated neutrophils. 1988 Biosci. Rep. pmid:2840131
Altin JG and Bygrave FL Prostaglandin F2 alpha and the thromboxane A2 analogue ONO-11113 stimulate Ca2+ fluxes and other physiological responses in rat liver. Further evidence that prostanoids may be involved in the action of arachidonic acid and platelet-activating factor. 1988 Biochem. J. pmid:3128268
Yamada K et al. Parallel inhibition of platelet-activating factor-induced protein phosphorylation and serotonin release by K-252a, a new inhibitor of protein kinases, in rabbit platelets. 1988 Biochem. Pharmacol. pmid:3128296
Fernandez-Gallardo S et al. Biosynthesis of platelet-activating factor in glandular gastric mucosa. Evidence for the involvement of the 'de novo' pathway and modulation by fatty acids. 1988 Biochem. J. pmid:2848496
Slapke J et al. [Test hierarchy for the development of new drug action principles with the action site in phospholipid metabolism for bronchial asthma and pulmonary hypertension]. 1988 Prax Klin Pneumol pmid:3140230
Neuwirth R et al. Evidence for immunoglobulin Fc receptor-mediated prostaglandin2 and platelet-activating factor formation by cultured rat mesangial cells. 1988 J. Clin. Invest. pmid:3166467
Rossi AG et al. Stereospecific bioactions of 5-hydroxyeicosatetraenoate. 1988 FEBS Lett. pmid:3191990
Nakamura T et al. Effect of azelastine on the intracellular Ca2+ mobilization in guinea pig peritoneal macrophages. 1988 Eur. J. Pharmacol. pmid:2898372
Nolte D [Bronchial hyperreactivity: pingpong between cells, nerves and mediators]. 1988 Med. Klin. (Munich) pmid:3367876
Bratton DL et al. Effects of platelet activating factor and related lipids on phase transition of dipalmitoylphosphatidylcholine. 1988 Biochim. Biophys. Acta pmid:3370214
Wang J et al. The effects of endotoxin on platelet-activating factor synthesis in cultured rat glomerular mesangial cells. 1988 Biochim. Biophys. Acta pmid:3370222
Grue-Sørensen G et al. Derivatives of 2-methylenepropane-1,3-diol as new antagonists of platelet activating factor. 1988 J. Med. Chem. pmid:3373485
Pirotzky E et al. Protection of platelet-activating factor-induced acute renal failure by BN 52021. 1988 Br J Exp Pathol pmid:3377967
Csatò M and Czarnetzki BM Effect of BN 52021, a platelet activating factor antagonist, on experimental murine contact dermatitis. 1988 Br. J. Dermatol. pmid:3377969
Hoffman DR et al. Platelet-activating factor induces glycogen degradation in fetal rabbit lung in utero. 1988 J. Biol. Chem. pmid:3379072
Kertscher HP et al. [Synthesis and thrombocyte-aggregating action of a structural analog of platelet activating factor with a modified head group]. 1988 Pharmazie pmid:3380866
Achterrath-Tuckermann U et al. Azelastine, a new antiallergic/antiasthmatic agent, inhibits PAF-acether-induced platelet aggregation, paw edema and bronchoconstriction. 1988 Pharmacology pmid:3380879
Myers AK et al. Antagonism of PAF-induced death in mice. 1988 Prostaglandins pmid:3131837
Kornecki E and Ehrlich YH Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor. 1988 Science pmid:3381103
Handley DA et al. Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412. 1988 J. Pharmacol. Exp. Ther. pmid:3183958
Shalit M et al. Platelet activating factor increases expression of complement receptors on human neutrophils. 1988 J. Leukoc. Biol. pmid:2842423
Etienne A et al. Role of neutrophils in gastric damage induced by platelet activating factor. 1988 Naunyn Schmiedebergs Arch. Pharmacol. pmid:3244384
Abraham WM The role of leukotrienes in allergen-induced late responses in allergic sheep. 1988 Ann. N. Y. Acad. Sci. pmid:2837960
Tomooka M et al. [Azelastine inhibits bronchoconstriction induced by histamine and leukotriene C4]. 1988 Arerugi pmid:2906534
Mazière JC et al. PAF-acether decreases low density lipoprotein degradation and alters lipid metabolism in cultured human fibroblasts. 1988 FEBS Lett. pmid:3402608
Godfroid JJ and Heymans F Chemistry of PAF antagonists. 1988 Prog Biochem Pharmacol pmid:3043433
Casals-Stenzel J and Heuer H Pharmacology of PAF antagonists. 1988 Prog Biochem Pharmacol pmid:3043436
Rola-Pleszczynski M PAF in cellular immunology. 1988 Prog Biochem Pharmacol pmid:3043437
Baggiolini M et al. Effects of PAF on neutrophils and mononuclear phagocytes. 1988 Prog Biochem Pharmacol pmid:3043438
Ojima-Uchiyama A et al. Phospholipid analysis of human eosinophils: high levels of alkylacylglycerophosphocholine (PAF precursor). 1988 Lipids pmid:3185116
Skeaff CM and Holub BJ The effect of fish oil consumption on platelet aggregation responses in washed human platelet suspensions. 1988 Thromb. Res. pmid:3187952
Griffin KJ and Levy JV The thieno-triazolodiazepine WEB 2086 inhibits platelet aggregation and ATP release from porcine platelets induced by platelet activating factor (PAF). 1988 Thromb. Res. pmid:3187959
Dawson J et al. Platelet activating factor as a mediator of equine cell locomotion. 1988 Vet. Res. Commun. pmid:3188378
Satoh K et al. [Endothelial injury as an initiating factor: vascular endothelial cell injury and biosynthesis of PAF]. 1988 Nippon Rinsho pmid:3404682
Nogami M et al. [Effects of a PAF antagonist CV-3988 on the acute gastric erosions of rats by water-immersion stress]. 1988 Nihon Shokakibyo Gakkai Zasshi pmid:3404759
Biologically active ether lipids. 1988 Prog Biochem Pharmacol pmid:3405995
Taira M et al. Lack of involvement of leukotriene and platelet activating factor in passive cutaneous anaphylaxis in rats. 1988 Agents Actions pmid:3407549
Mollinedo F et al. Intracellular localization of platelet-activating factor synthesis in human neutrophils. 1988 Biochem. Biophys. Res. Commun. pmid:3408495
Hirafuji M et al. Transient increase of cytosolic free calcium in cultured human vascular endothelial cells by platelet-activating factor. 1988 Biochem. Biophys. Res. Commun. pmid:3408504
Stahl GL et al. Salutary consequences of blockade of platelet activating factor in hemorrhagic shock. 1988 Eur. J. Pharmacol. pmid:3409951
Kroegel C et al. Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils. 1988 Immunology pmid:3410498
Takizawa H et al. Bronchoconstriction induced by platelet-activating factor in the guinea pig and its inhibition by CV-3988, a PAF antagonist: serial changes in findings of lung histology and bronchoalveolar lavage cell population. 1988 Int. Arch. Allergy Appl. Immunol. pmid:3410557
Ohmori K et al. Antiinflammatory and antiallergic effects of a novel metabolite of Nocardiopsis sp. as a potent protein kinase C inhibitor from microbial origin. 1988 Arzneimittelforschung pmid:2972291
Masugi F et al. Platelet-activating factor and anti-platelet-aggregating factor in acute reduction of blood pressure following percutaneous transluminal renal angioplasty in patients with renovascular hypertension. 1988 J Hum Hypertens pmid:2977405
Bussolino F et al. Platelet activating factor induces dopamine release in PC-12 cell line. 1988 Am. J. Physiol. pmid:3177629
Gay JC and Stitt ES Platelet-activating factor induces protein kinase activity in the particulate fraction of human neutrophils. 1988 Blood pmid:2825844
Hill CE et al. Location of platelet activating factor binding in rat liver. 1988 Biochem. J. pmid:3178735
Crouch MF and Lapetina EG Spacial isolation of protein kinase C activation in thrombin stimulated human platelets. 1988 Biochem. Biophys. Res. Commun. pmid:3178827
Michel L et al. Biosynthesis of paf-acether factor-acether by human skin fibroblasts in vitro. 1988 J. Immunol. pmid:3397536
Andersson M and Pipkorn U The effect of platelet activating factor on nasal hypersensitivity. 1988 Eur. J. Clin. Pharmacol. pmid:3181276
Adamus WS et al. Inhibitory effect of oral WEB 2086, a novel selective PAF-acether antagonist, on ex vivo platelet aggregation. 1988 Eur. J. Clin. Pharmacol. pmid:3181277
Yanoshita R et al. Hydrolysis of platelet activating factor and its methylated analogs by acetylhydrolases. 1988 J. Biochem. pmid:3182751
Lakin KM [Problems of a pharmacologic search for inhibitors of platelet aggregation]. 1988 Kardiologiia pmid:3066962
Soybel DI et al. Effects of platelet-activating factor on canine gastric mucosal blood flow and permeability to luminal acid. 1988 Am. J. Surg. pmid:3341532
Kawaguchi H et al. [Effect of platelet-activating factor (PAF) on blood pressure, peripheral, coronary and renovascular system]. 1988 Kokyu To Junkan pmid:3067285
Kumar R et al. Occurrence of platelet-activating factor in rabbit spermatozoa. 1988 Arch. Biochem. Biophys. pmid:3341753
Huo YN et al. A preferential inhibition by Zn2+ on platelet activating factor- and thrombin-induced serotonin secretion from washed rabbit platelets. 1988 Arch. Biochem. Biophys. pmid:3341767
Whatley RE et al. The regulation of synthesis of platelet-activating factor by endothelial cells. 1988 Chest pmid:3342689
Ukena D et al. Radioligand binding of antagonists of platelet-activating factor to intact human platelets. 1988 FEBS Lett. pmid:3342883
Suzuki Y et al. Release of acetylhydrolase from platelets on aggregation with platelet-activating factor. 1988 Eur. J. Biochem. pmid:3345757
Benveniste J and Leyravaud S Retention of platelet activating factor by human neutrophils. 1988 J. Immunol. pmid:3346547
Immunomodulation: other approaches. 1988 Transplant. Proc. pmid:3347955
Lang CH et al. Platelet-activating factor-induced increases in glucose kinetics. 1988 Am. J. Physiol. pmid:3348371
Touvay C et al. Role of platelet-activating factor (PAF) in the bronchopulmonary alterations and beta-adrenoceptor function induced by endotoxin. 1988 Biochem. Biophys. Res. Commun. pmid:2835036
17th annual UCLA symposium. Abstracts: Cell activation and signal initiation: receptor and phospholipase control of inositol phosphate, PAF and eicosanoid production. 1988 J. Cell. Biochem. Suppl. pmid:2835556
Dembińska-Kieć A et al. Release of cysteinyl-leukotrienes is of minor importance in PAF induced reduction of perfusion rate in the gastric vascular bed. 1988 Biomed. Biochim. Acta pmid:3248109
Ostermann G et al. Structure-activity relationships of synthetic analogues of platelet-activating factor. 1988 Biomed. Biochim. Acta pmid:3248110
Droy-Lefaix MT et al. The amplificative role of PAF-acether in the oxidative stress following reperfusion of ischemic stomach. 1988 Basic Life Sci. pmid:3250539
Paulson SK and Nicholson NS A radioreceptor binding assay for measurement of platelet-activating factor synthesis by human neutrophils. 1988 J. Immunol. Methods pmid:2837517
Stahl GL et al. Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia. 1988 J. Pharmacol. Exp. Ther. pmid:3252036
Williams WR et al. Plates and anti-asthma drugs. 1988 Pneumonol Pol pmid:3254508
Archer CB Mediators of heat urticaria. 1988 Clin. Exp. Dermatol. pmid:3256463
Morell GP et al. Paf-acether (platelet-activating factor) and interleukin-1-like cytokine production by lipopolysaccharide-stimulated glomeruli. 1988 Clin. Immunol. Immunopathol. pmid:3257432
Pignol B et al. Potentiation of immunosuppressive action of cyclosporine A by platelet-activating factor antagonists: an approach of the mechanism of action of these drugs in the prevention of graft rejection. 1988 Transplant. Proc. pmid:3259039
Bussolino F et al. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha. 1988 J. Biol. Chem. pmid:3261295
Garcia JG et al. Effect of platelet activating factor on leukocyte-endothelial cell interactions. 1988 Thromb. Res. pmid:2842887
Ng DS and Wong K Specific binding of platelet-activating factor (PAF) by human peripheral blood mononuclear leukocytes. 1988 Biochem. Biophys. Res. Commun. pmid:2843182
Browne PC et al. Kinetics of the formation of thrombin-thrombospondin complexes: involvement of a 77-kDa intermediate. 1988 Arch. Biochem. Biophys. pmid:2844122
Stephens LR et al. Synthesis of myo-inositol 1,3,4,5,6-pentakisphosphate from inositol phosphates generated by receptor activation. 1988 Biochem. J. pmid:2845930
Ukena D and Sybrecht GW [Function of platelet activating factor in asthma]. 1988 Dtsch. Med. Wochenschr. pmid:2846251
Ng DS and Wong K Effect of sulfhydryl reagents on PAF binding to human neutrophils and platelets. 1988 Eur. J. Pharmacol. pmid:2846326
Storch J et al. Influence of platelet activating factor and a nonmetabolizable analogue on superoxide production by bone marrow derived macrophages. 1988 J. Leukoc. Biol. pmid:2846728
Miller MJ et al. SOD prevents damage and attenuates eicosanoid release in a rabbit model of necrotizing enterocolitis. 1988 Am. J. Physiol. pmid:2847541
Schindler PW et al. Fluorophore-labeled ether lipids: substrates for enzymes of the platelet-activating factor cycle in peritoneal polymorphonuclear leukocytes. 1988 Anal. Biochem. pmid:3239750
Silva PM et al. Adrenalectomy exacerbates paw edema without interfering with desensitization induced by PAF-acether in rats. 1988 Braz. J. Med. Biol. Res. pmid:3240383
Fichelle J et al. Bronchospasmolytic effects of RU 42173. 1988 Fundam Clin Pharmacol pmid:3240917
Misawa M and Takata T [Effects of platelet activating factor on the bronchial musculature and vasculature in dogs]. 1988 Nihon Kyobu Shikkan Gakkai Zasshi pmid:3241511
Yasuda K et al. Acyl type platelet-activating factor in normal rat uterus determined by gas chromatography mass spectrometry. 1988 Biomed. Environ. Mass Spectrom. pmid:3242662
Perico N et al. Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney. 1988 Lab. Invest. pmid:3123798
Mallet AI Analysis of lyso-platelet activating factor by negative ion gas chromatography/mass spectrometry of the nitrobenzal acetal derivatives. 1988 Biomed. Environ. Mass Spectrom. pmid:3242671
Suzuki S et al. [Effect of a specific antagonist of platelet-activating factor, FR-900452, on proteinuria and urinary thromboxane excretion in aminonucleoside nephrotic rats]. 1988 Nihon Jinzo Gakkai Shi pmid:3244194
Sueoka K et al. Platelet activating factor-induced early pregnancy factor activity from the perfused rabbit ovary and oviduct. 1988 Am. J. Obstet. Gynecol. pmid:3207134